RGNX
Price
$9.11
Change
-$0.04 (-0.44%)
Updated
Apr 28, 04:58 PM (EDT)
Capitalization
458.57M
2 days until earnings call
XENE
Price
$37.88
Change
+$0.26 (+0.69%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
2.88B
15 days until earnings call
Ad is loading...

RGNX vs XENE

Header iconRGNX vs XENE Comparison
Open Charts RGNX vs XENEBanner chart's image
REGENXBIO
Price$9.11
Change-$0.04 (-0.44%)
Volume$7.67K
Capitalization458.57M
Xenon Pharmaceuticals
Price$37.88
Change+$0.26 (+0.69%)
Volume$5.41K
Capitalization2.88B
RGNX vs XENE Comparison Chart
Loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGNX vs. XENE commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGNX is a Buy and XENE is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (RGNX: $9.15 vs. XENE: $37.62)
Brand notoriety: RGNX and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGNX: 59% vs. XENE: 65%
Market capitalization -- RGNX: $458.57M vs. XENE: $2.88B
RGNX [@Biotechnology] is valued at $458.57M. XENE’s [@Biotechnology] market capitalization is $2.88B. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGNX’s FA Score shows that 1 FA rating(s) are green whileXENE’s FA Score has 2 green FA rating(s).

  • RGNX’s FA Score: 1 green, 4 red.
  • XENE’s FA Score: 2 green, 3 red.
According to our system of comparison, XENE is a better buy in the long-term than RGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGNX’s TA Score shows that 5 TA indicator(s) are bullish while XENE’s TA Score has 6 bullish TA indicator(s).

  • RGNX’s TA Score: 5 bullish, 5 bearish.
  • XENE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, XENE is a better buy in the short-term than RGNX.

Price Growth

RGNX (@Biotechnology) experienced а +54.04% price change this week, while XENE (@Biotechnology) price change was +7.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.03%. For the same industry, the average monthly price growth was +0.98%, and the average quarterly price growth was -8.84%.

Reported Earning Dates

RGNX is expected to report earnings on Jul 30, 2025.

XENE is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+11.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XENE($2.88B) has a higher market cap than RGNX($459M). RGNX YTD gains are higher at: 18.370 vs. XENE (-4.031). RGNX has higher annual earnings (EBITDA): -198.23M vs. XENE (-276.74M). XENE has more cash in the bank: 627M vs. RGNX (235M). XENE has less debt than RGNX: XENE (9.02M) vs RGNX (82M). RGNX has higher revenues than XENE: RGNX (83.3M) vs XENE (0).
RGNXXENERGNX / XENE
Capitalization459M2.88B16%
EBITDA-198.23M-276.74M72%
Gain YTD18.370-4.031-456%
P/E RatioN/AN/A-
Revenue83.3M0-
Total Cash235M627M37%
Total Debt82M9.02M910%
FUNDAMENTALS RATINGS
RGNX vs XENE: Fundamental Ratings
RGNX
XENE
OUTLOOK RATING
1..100
718
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
10031
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
8573
P/E GROWTH RATING
1..100
174
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RGNX's Valuation (76) in the Biotechnology industry is in the same range as XENE (98). This means that RGNX’s stock grew similarly to XENE’s over the last 12 months.

XENE's Profit vs Risk Rating (31) in the Biotechnology industry is significantly better than the same rating for RGNX (100). This means that XENE’s stock grew significantly faster than RGNX’s over the last 12 months.

XENE's SMR Rating (94) in the Biotechnology industry is in the same range as RGNX (98). This means that XENE’s stock grew similarly to RGNX’s over the last 12 months.

XENE's Price Growth Rating (73) in the Biotechnology industry is in the same range as RGNX (85). This means that XENE’s stock grew similarly to RGNX’s over the last 12 months.

XENE's P/E Growth Rating (4) in the Biotechnology industry is in the same range as RGNX (17). This means that XENE’s stock grew similarly to RGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RGNXXENE
RSI
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
83%
Momentum
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
77%
MACD
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
87%
Bullish Trend 7 days ago
75%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 12 days ago
73%
Declines
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 25 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
71%
Aroon
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
79%
View a ticker or compare two or three
Ad is loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA284.9525.44
+9.80%
Tesla
GME27.460.38
+1.40%
GameStop Corp
SPY550.643.95
+0.72%
SPDR® S&P 500® ETF
AAPL209.280.91
+0.44%
Apple
BTC.X93754.840000-892.085940
-0.94%
Bitcoin cryptocurrency

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with RCKT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-0.54%
RCKT - RGNX
58%
Loosely correlated
-2.69%
DNLI - RGNX
55%
Loosely correlated
+1.23%
NTLA - RGNX
53%
Loosely correlated
+1.59%
ARWR - RGNX
53%
Loosely correlated
-0.67%
BEAM - RGNX
51%
Loosely correlated
-3.22%
More

XENE and

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
-1.52%
IDYA - XENE
53%
Loosely correlated
-0.37%
KYMR - XENE
52%
Loosely correlated
-0.89%
ATXS - XENE
51%
Loosely correlated
-0.77%
RCKT - XENE
50%
Loosely correlated
-2.69%
RGNX - XENE
49%
Loosely correlated
-0.54%
More